Track Tyche Industries Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: -4.46 %
Low
120.0
High
130.0
1 Month returns: -2.40 %
Low
120.0
High
135.7
1 Year returns: -15.21 %
Low
99.0
High
148.0
3 Year CAGR: -12.75 %
Low
99.0
High
230.0
5 Year CAGR: -10.68 %
Low
99.0
High
230.0
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Tyche Industries Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Tyche Industries Ltd. Shareholding Pattern
Quarterly breakdown of Tyche Industries Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Tyche Industries Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Tyche Industries Ltd.?
The current share price of Tyche Industries Ltd. is ₹ 122.10 as of 10 Jul 2026.
What is the market capitalisation of Tyche Industries Ltd.?
The market capitalisation of Tyche Industries Ltd. stands at ₹ 125.15 Cr.
What is the PE ratio of Tyche Industries Ltd.?
The Price-to-Earnings (PE) ratio of Tyche Industries Ltd. is 18.04 as of the latest trailing twelve months data.
What is the ROE and ROCE of Tyche Industries Ltd.?
Tyche Industries Ltd. has a Return on Equity (ROE) of 5.01% and a Return on Capital Employed (ROCE) of 0.17% as per the latest financial reports.
What is the 52-week high and low of Tyche Industries Ltd.?
The 52-week high of Tyche Industries Ltd. is - and the 52-week low is -.
What is the dividend yield of Tyche Industries Ltd.?
The dividend yield of Tyche Industries Ltd. is 2.46% based on the current market price.
What is the FII and DII holding in Tyche Industries Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 30.84% of Tyche Industries Ltd. shares.
What sector does Tyche Industries Ltd. belong to?
Tyche Industries Ltd. operates in the Healthcare sector.
What is the beta of Tyche Industries Ltd.?
The beta of Tyche Industries Ltd. is 0.76, indicating its price volatility relative to the broader market. Over the past 1 year, Tyche Industries Ltd. has delivered an absolute return of -16.94%.
What is the RSI of Tyche Industries Ltd.?
The 14-day Relative Strength Index (RSI) of Tyche Industries Ltd. is 39.30, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Tyche Industries Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
PE TTM of 18.04 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -41.86%
What is P/E Ratio?
Median: 31.03
Value 18.04
-215.443203.67
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.0 as on 31 Mar 2026 and Debt to Equity remained same in the last 1 year
What is Debt to Equity?
Consistently pays dividend
The company has not missed dividend payments once in the last 10 financial years
What is Dividend streak?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Low and declining ROE
The company reported low ROE of 5.01% for 12-month ended 31 Mar 2026 and ROE declined by -440 bps from 1 year ago
What is ROE (FY)?
Low and declining operating margin
The company reported low operating margin of 0.45% for 12-month ended 31 Mar 2026 and operating margin declined by -1376 bps from 1 year ago
What is Operating profit margin?
Low revenue growth and lower than median growth of industry
The company delivered moderate revenue growth of -18.08% for 12-month ended 31 Mar 2026 and the growth was 29.32 percentage points lower than median growth of industry
What is Sales growth (1Y)?
Median: 11.24
Value -18.08
-82.35114662
Low EPS growth and lower than median growth of industry
The company delivered moderate EPS growth of -44.68% for 12-month ended 31 Mar 2026 and the growth was 52.8 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Neutral
Company's earnings are of moderate quality
Earnings quality score of 51.2 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
51.2 / 100
Moderate dividend yield
The company has a moderate dividend yield of 2.46%
What is Dividend yield?
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0699798.
Holdings and Presence
Indices and prominent investors with a stake in this stock.
Index Presence
Tyche Industries Ltd. is not part of any tracked index.
Overview of Tyche Industries Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Tyche Industries Limited is an India-based company engaged in manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates of APIs. The Company operates through the Bulk Drugs segment. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal and others. Its intermediates include 4-(3,4-Dichlorophenyl)-1-tetralone, 1-Benzylpiperidine-4-Carboxaldehyde (BPCA), 3-Hydroxymethyl quinuclidine Hcl, and others. Its chiral intermediates include S-(+)-3-Quinuclidinol, R-(-)-3-Quinuclidinol and others. The Companys nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.
Tyche Industries Limited is an India-based company engaged in manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates of APIs. The Company operates through the Bulk Drugs segment. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Suc...